Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised
by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid …

The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a
hypercoagulability associated to vascular thrombosis and/or obstetric morbidity, is caused …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies that have clear
associations with thrombosis and pregnancy morbidity, and which together constitute the …

Chronic kidney disease (CKD) affects approximately 10% of the world's adult population; it is
within the top 20 causes of death worldwide, and its impact on patients and their families can …

The pathological features of antiphospholipid syndrome (APS) are related to the activity of
circulating antiphospholipid antibodies (aPLs) associated with vascular thrombosis and …

Venous thromboembolism, usually entailing deep vein thrombosis, pulmonary embolism, or
both, is a complex and multifactorial disorder, in which a number of putative conditions …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease that is
characterized serologically by the presence of antiphospholipid antibodies (aPL) and …

Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased
risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies …

One of the main groups of lipids is phospholipids, which are mainly involved in forming cell
membranes. Neoplastic processes such as cell replication have increased lipid synthesis …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
thrombosis, pregnancy morbidity, or nonthrombotic manifestations in patients with …